A Double-Blind Study Comparing Daktacort®, Miconazole and Hydrocortisone in Inflammatory Skin Infections

Publisher Website
Google Scholar
Abstract
In a 4-week double-blind trial, Daktacort® cream was compared with each of its constituents (i.e. miconazole 2% and hydrocortisone 1%) in a total of 63 patients (aged 12–60 years) with inflamed skin infections of bacterial or mycotic origin. Daktacort treatment induced a significant improvement of all symptoms within 1 week and was superior to both miconazole and hydrocortisone in suppressing the inflammation. This tendency persisted throughout the trial but at the end miconazole treatment proved also superior to hydrocortisone.

This publication has 0 references indexed in Scilit: